Recent observations provided a better insight on how PNPLA3 expression is regulated during development of human NASH, highlighting that in early phases, PNPLA3 strongly correlates with α-SMA and is present in α-SMA-positive cells [20]. This evidence concerns the gene ACTA1 and metabolic dysfunction-associated steatohepatitis.